Cyclin E Overexpression and Breast Cancer
Author Information
Author(s): NH Nielsen, C Arnerlov, SO Emdin, G Landberg
Primary Institution: University of Umea
Hypothesis
Is cyclin E overexpression a negative prognostic factor in breast cancer?
Conclusion
High levels of cyclin E in breast cancer patients are associated with an increased risk of death and relapse.
Supporting Evidence
- Patients with high cyclin E levels had a significantly increased risk of death and relapse from breast cancer.
- There was a strong association between cyclin E expression and oestrogen receptor status.
- High cyclin E expression was found predominantly in oestrogen receptor-negative tumors.
Takeaway
This study found that patients with high levels of a protein called cyclin E in their breast tumors are more likely to have serious health problems from their cancer.
Methodology
The study analyzed cyclin E expression in 114 tumor specimens from breast cancer patients using Western blotting.
Limitations
Some patients were excluded due to other cancers or distant metastases, which may limit the generalizability of the findings.
Participant Demographics
Patients were women with primary breast cancer treated at Umea University Hospital between 1988-1991.
Statistical Information
P-Value
0.0002
Statistical Significance
p<0.00001
Want to read the original?
Access the complete publication on the publisher's website